Изследователски екипи

Последно актуализиране :
28/04/2024

Изследователски екипи - M.D.Anderson Cancer Center

M.D.Anderson Cancer Center

Houston

almyers@mdanderson.org

Библиография

(138)

Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration.
Kawedia J, Ramchandran S, Liu X, Gulbis A, Titus M, Bashir Q, Qazilbash M, Champlin R, Ciur S, (jdkawedia@mdanderson.org)
Am J Health-Syst Pharm - 2022 - ;79,12: 1011-1018

Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration.
Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M. (almyers@mdanderson.org)
Drugs R D - 2017 -

Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer
Kawedia L.D, Zhang Y-P, Myers A.L, Richards-Kortum R.R, Kramer M.A, Gillenwater A.M, Culotta K.S. (jdkawedia@mdanderson.org)
J Oncol Pharm Practice - 2016 - ; 22: 21-25

Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags.
Myers A.Ls, Zhang Y-P, Kawedia L, Trinh V.A, Tran H, Smith J.A, Kramer M.A. (almyers@mdanderson.org)
J Oncol Pharm Practice - 2016 - ; 22: 31-36.

Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags
Myers A.L, Zhang Y, . Kawedia J.D, Shank B.R, Deaver M.A, Kramer M.A. (almyers@mdanderson.org)
Am J Health-Syst Pharm - 2016 - ; 73,24: 2083-2088.

Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion.
Zhang, Y., Kawedia, J.D., Myers, A.L., McIntyre, C.M., Anderson, P.M., Kramer, M.A., Culotta, K. (jdkawedia@mdanderson.org)
J Oncol Pharm Practice - 2014 - ; 20, 1: 51-57.

Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions.
Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T. (jdkawedia@mdanderson.org)
J Oncol Pharm Practice - 2014 - ; 20, 1: 58-64.

Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. ()
Am J Health-Syst Pharm - 2011 - ; 68: 2163-2169.

Compatibility and stability of palonosetron hydrochloride and propofol during simulated Y-site administration.
Trissel L.A, Trusley C, Kupiec T.C, Ben M. ()
Int J Pharm Compound - 2009 - ; 13, 1: 78-80.

Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration.
Trusley C, Ben M, Kupiec TC, Trissel LA. ()
Int J Pharm Compound - 2008 - ; 12, 2: 156-160.

Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated Y-site administration.
Kupiec T, Ben M, Trusley C, Trissel LA. ()
Int J Pharm Compound - 2008 - ; 12,2: 170-173.

Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Chan P, Heatherly K, Kupiec T.C, Trissel L.A. ()
Int J Pharm Compound - 2008 - ; 12, 3: 276-278.

Compatibility of doripenem with other drugs during simulated Y-site administratioN
Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. ()
Am J Health-Syst Pharm - 2008 - ; 65: 1261-1265.

Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. ()
Am J Health-Syst Pharm - 2008 - ; 65, 16: 1545-1551.

Physical and chemical stability of esomeprazole sodium solutions.
Kupiec TC, Aloumanis V, Ben M, Trissel LA, Chan P, Patterson J. ()
Ann Pharmacotherapy - 2008 - ; 42, 9: 1247-1251.

Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
Kupiec T, Trusley C, Ben M, Trissel LA. ()
Am J Health-Syst Pharm - 2008 - ; 65, 18: 1735-1759.

Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration.
Ben M, Trusley C, Kupiec TC, Trissel LA. ()
Int J Pharm Compound - 2008 - ; 12, 4: 368-371.

Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated Y-site administration.
Trusley C, Ben M, Kupiec TC, Trissel LA. ()
Int J Pharm Compound - 2007 - ; 11, 1: 82-85.

Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during Y-site administration.
Trissel LA, Trusley C, Ben M, Kupiec TC. ()
Am J Health-Syst Pharm - 2007 - ; 64, 11: 1209-1213.

Palonosetron hydrochloride compatibility and stability with three beta-lactam antibiotics during simulated Y-site administration.
Ben M, Trusley C,Kupiec T.C, Trissel L.A. ()
Int J Pharm Compound - 2007 - ; 11, 6: 520-524.

Extended stability of oxytocin in common infusion solutions.
Trissel LA, Zhang Y, Douglass K, Kastango E. ()
Int J Pharm Compound - 2006 - ; 10: 156-158.

Physical and chemical stability of palonosetron hydrochloride with dacarbazine and with methylprednisolone sodium succinate during simulated Y-site administration.
Trissel LA, Zhang Y, Xu QA. ()
Int J Pharm Compound - 2006 - ; 10: 234-236.

Compatibility of micafungin injection with other drugs during simulated Y-site co-administration.
Trusley C, Kupiec TC, Trissel LA. ()
Int J Pharm Compound - 2006 - ; 10: 230-232.

Physical and chemical stability of pemetrexed in infusion solutions.
Zhang Y, Trissel LA. ()
Ann Pharmacotherapy - 2006 - ; 40, 6: 1082-1085.

Physical instability of frozen pemetrexed solutions in PVC bags.
Zhang Y, Trissel LA. ()
Ann Pharmacotherapy - 2006 - ; 40, 7: 1289-1292.

Drug compatibility with new polyolefin infusion solution containers.
Trissel LA, Xu QA, Baker M. ()
Am J Health-Syst Pharm - 2006 - ; 63: 2379-2382.

Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Trissel LA, Zhang Y, Koontz SE. ()
Int J Pharm Compound - 2006 - ; 10, 5: 396-399.

Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
Trissel LA, Zhang Y. ()
Ann Pharmacotherapy - 2005 - ; 39: 280-283.

Physical and chemical stability of palonosetron hydrochloride with lorazepam and midazolam hydrochloride during simulated Y-site administration.
Trissel LA, Xu QA. ()
Int J Pharm Compound - 2005 - ; 9, 3: 235-237.

Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration.
Trissel LA, Xu QA. ()
Int J Pharm Compound - 2005 - ; 9, 3: 238-241.

Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Trissel LA, Ogundele AB. ()
Am J Health-Syst Pharm - 2005 - ; 62: 834-837.

Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration.
Trissel LA, Zhang Y. ()
Int J Pharm Compound - 2005 - ; 2005, 9, 4: 320-322.

Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
Xu QA, Trissel LA. ()
Am J Health-Syst Pharm - 2005 - ; 62: 1998-2000.

Physical and chemical stability of pemetrexed solutions in plastic syringes.
Zhang Y, Trissel LA. ()
Ann Pharmacotherapy - 2005 - ; 39, 12: 2026-2028.

Physical and chemical stability of treprostinil sodium injection packaged in plastic syringe pump reservoirs.
Xu QA, Trissel LA, Pham L. ()
Int J Pharm Compound - 2004 - ; 8, 3: 228-230.

Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Trissel LA, Zhang Y. ()
Int J Pharm Compound - 2004 - ; 8, 3: 231-235.

Compatibility and stability of Aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate.
Trissel LA, Zhang Y. ()
Int J Pharm Compound - 2004 - ; 8,5: 398-403.

Physical and chemical stability of palonosetron HCl in 4 infusion solusions.
Trissel LA, Xu QA. ()
Ann Pharmacotherapy - 2004 - ; 38: 1608-1611.

Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration.
Xu QA, Trissel LA. ()
Am J Health-Syst Pharm - 2004 - ; 61: 1596-1598.

Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin and oxaliplatin during simulated Y-site administration.
Trissel LA, Yanping Z. ()
J Oncol Pharm Practice - 2004 - ; 10: 191-195.

Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Trissel LA, Saenz CA, Ogundele AB, Ingram DS. ()
Am J Health-Syst Pharm - 2004 - ; 61: 2289-2293.

Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. ()
Am J Health-Syst Pharm - 2003 - ; 60: 80-85.

Stability of imipenem-cilastatin sodium in autodose infusion system bags.
Trissel LA, Xu QA. ()
Hosp Pharm - 2003 - ; 38: 130-134.

Stability of clindamycin phosphate in autodose infusion system bags.
Xu QA, Trissel LA. ()
Int J Pharm Compound - 2003 - ; 7, 2: 149-151.

Stability of amikacin sulfate in autodose infusion system bags.
Zhang Y, Trissel LA. ()
Int J Pharm Compound - 2003 - ; 7, 3: 230-232.

Physical compatibility of antithymocyte globulin (rabbit) with heparin sodium and hydrocortisone sodium succinate.
Trissel LA, Seanz C. ()
Am J Health-Syst Pharm - 2003 - ; 60: 1650-1652.

Stability of cefepime hydrochloride in autodose infusion system bags.
Trissel LA, Xu QA. ()
Ann Pharmacotherapy - 2003 - ; 37, 6: 804-807.

Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system.
Hildebrand KR, Elsberry DD, Hassenbusch SJ. ()
J Pain Symptom Manage - 2003 - ; 25, 5: 464-471.

Stability and compatibility of alfentanil hydrochloride and morphine sulfate in poypropylene syringes.
Sharley NA, Burgess NG. ()
J Pharm Pract and Res - 2003 - ; 33: 279-281.

Stability of fenoldopam in two infusion solutions.
Trissel LA, Zhang Y, Baker MB. ()
Am J Health-Syst Pharm - 2002 - ; 59: 846-848.

Physical and chemical stability of methotrexate, cytarabine, and hydrocortisone in Elliott’s B Solution for intrathecal use.
Trissel LA, King KM, Zhang Y, Wood AM. ()
J Oncol Pharm Practice - 2002 - ; 8: 27-32.

Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA, Ingram DS, Ogundele AB. ()
J Oncol Pharm Practice - 2002 - ; 8: 33-37.

Stability of 4-Aminopyridine and 3,4-Diaminopyridine oral capsules
Trissel LA, Zhang Y, Xu QA. ()
Int J Pharm Compound - 2002 - ; 6, 2: 155-157.

Stability of gentamicin sulfate and tobramycin sulfate in autodose infusion system bags.
Xu QA, Trissel LA, Saenz A. ()
Int J Pharm Compound - 2002 - ; 6: 152-154.

Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose system bags.
Zhang Y, Trissel LA. ()
Int J Pharm Compound - 2002 - ; 6: 226-229.

Physical and chemical stability of hydromorphone hydrochloride 1.5 and 80 mg/ml packaged in plastic syringes.
Trissel LA, Xu QA. ()
Int J Pharm Compound - 2002 - ; 6: 74-76.

Physical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringes.
Trissel LA, Xu QA, Pham L. ()
Int J Pharm Compound - 2002 - ; 6: 70-73.

Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes.
Xu QA, Trissel LA, Pham L. ()
Int J Pharm Compound - 2002 - ; 6: 66-69.

Physical and chemical stability of morphine sulfate 5 mg/ml and 50 mg/ml packaged in plastic syringes.
Trissel LA, Xu QA. ()
Int J Pharm Compound - 2002 - ; 6: 62-65.

Compatibility screening of Precedex during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA. ()
Int J Pharm Compound - 2002 - ; 6: 230-233.

Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Trissel LA, Saenz CA. ()
Int J Pharm Compound - 2002 - ; 6: 311-315.

Stability of three cephalosporin antibiotics in autodose infusion system bags.
Xu QA, Trissel LA, Saenz CA et al. ()
J Am Pharm Assoc - 2002 - ; 42: 428-431.

Stability of methylprednisolone sodium succinate in autodose infusion system bags.
Trissel LA, Zhang Y. ()
J Am Pharm Assoc - 2002 - ; 42: 868-870.

The stablity of diluted vincristine sulfate used as a deterrent to inadvertent intrathecal injection.
Trissel LA, Zhang Y, Cohen MR. ()
Hosp Pharm - 2001 - ; 36: 740-745.

Stability of ciprofloxacin and vancomycin hydrochloride in autodose infusion system bags.
Trissel LA, Xu QA, Zhang Y, Saenz CA, Ingram DS. ()
Hosp Pharm - 2001 - ; 36: 1170-1173.

Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Trissel LA, Saenz C, Williams YW, Ingram D. ()
Int J Pharm Compound - 2001 - ; 5: 314-321.

Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Trissel LA, Williams KY, Baker MB. ()
Int J Pharm Compound - 2001 - ; 5: 69-72.

Stability of piperacillin and ticarcillin in autodose infusion system bags.
Zhang Y, Trissel LA. ()
Ann Pharmacotherapy - 2001 - ; 35: 1360-1363.

Incompatibility of erythromycin lactobionate and sulfamethoxazole/trimethoprim with linezolid injection.
Trissel LA, Zhang Y, Xu QA. ()
Hosp Pharm - 2000 - ; 35: 1192-1196.

Compatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodium.
Zhang Y, Xu QA, Trissel LA, Willimas KY. ()
J Am Pharm Assoc - 2000 - ; 40: 520-524.

Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
Xu QA, Trissel LA, Williams KY. ()
J Am Pharm Assoc - 2000 - ; 40: 509-514.

Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
Zhang Y, Xu QA, Trissel LA, Williams KY. ()
Ann Pharmacotherapy - 2000 - ; 34: 996-1001.

Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
Trissel LA , Williams KY, Gilbert DL. ()
J Am Pharm Assoc - 2000 - ; 40: 515-519.

Compatibility and stability of linezolid injection admixted with gentamicin sulfate and tobramycin sulfate.
Xu Q.A, Trissel L.A, Zhang Y, Williams K.Y. ()
Int J Pharm Compound - 2000 - ; 4, 6: 476-479.

Naratriptan hydrochloride in extemporaneously compounded oral suspensions.
Zhang YP, Trissel LA, Fox JL. ()
Int J Pharm Compound - 2000 - ; 4: 69-71.

Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Wolkin AC. ()
Int J Pharm Compound - 1999 - ; 3: 241-244.

Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF, Simmons M. ()
J Am Pharm Assoc - 1999 - ; 39: 141-145.

Physical and chemical stability of etoposide phosphate solutions.
Zhang Y, Trissel LA. ()
J Am Pharm Assoc - 1999 - ; 39: 146-150.

Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M. ()
JPEN - 1999 - ; 23: 67-74.

Physical and chemical stability of gemcitabine hydrochloride solutions.
Xu QA, Zhang Y, Trissel LA. ()
J Am Pharm Assoc - 1999 - ; 39: 509-513.

Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF, Gilbert DL. ()
J Am Pharm Assoc - 1999 - ; 39: 514-518.

Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. ()
Hosp Pharm - 1998 - ; 33: 1515-1522.

Stability of cisatracurium besylate in vials, syringes and infusion admixtures.
Xu QA, Zhang YP, Trissel LA, Gilbert DL, Martinez JF, Fox JL. ()
Am J Health-Syst Pharm - 1998 - ; 55: 1037-1041.

Stability of acyclovir sodium 1, 7, and 10 mg/ml in 5% dextrose injection and in 0.9% sodium chloride injection.
Zhang Y, Trissel LA, Martinez JF, Gilbert DL. ()
Am J Health-Syst Pharm - 1998 - ; 55: 574-577.

Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. ()
Hosp Pharm - 1998 - ; 33: 284-292.

Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions.
Trissel LA, Xu QA, Gilbert DL. ()
Ann Pharmacotherapy - 1998 - ; 32: 1013-1016.

Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture.
Xu QA, Trissel LA, Gilbert DL. ()
Hosp Pharm - 1998 - ; 33: 1203-1207.

Stability of mechlorethamine hydrochloride 0.01% ointment in Aquafor Base.
Zhang Y, Trissel LA, Johansen JF, Kimball CL. ()
Int J Pharm Compound - 1998 - ; 2: 89-91.

Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. ()
Am J Health-Syst Pharm - 1997 - ; 54: 56-60.

Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF, Gilbert DL. ()
Am J Health-Syst Pharm - 1997 - ; 54: 1735-1741.

Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM. ()
Am J Health-Syst Pharm - 1997 - ; 54: 1295-1300.

Rapid loss of fentanyl citrate admixed with fluorouracil in polyvinyl chloride containers.
Xu QA, Trissel LA, Martinez JF. ()
Ann Pharmacotherapy - 1997 - ; 31: 297-302.

Stability of aminocaproic acid injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection.
Zhang YP, Trissel LA. ()
Int J Pharm Compound - 1997 - ; 1: 132-134.

Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Martinez JF, Trissel LA, Gilbert DL. ()
Int J Pharm Compound - 1997 - ; 1: 356-358.

Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration.
Gilbert DL, Trissel LA, Martinez JF. ()
Am J Health-Syst Pharm - 1997 - ; 54: 1193-1195.

Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF, Kim MC. ()
Am J Health-Syst Pharm - 1997 - ; 54: 2192-2196.

Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. ()
Am J Health-Syst Pharm - 1997 - ; 54: 2708-2713.

Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Trissel LA, Gilbert DL, Martinez JF. ()
Am J Health-Syst Pharm - 1997 - ; 54: 1287-1292.

Development of clonidine hydrochloride injections for epidural and intrathecal administration.
Trissel LA, Hassenbusch SJ. ()
Int J Pharm Compound - 1997 - ; 1: 274-277.

100

An automated process for determining the physical compatibility of drugs.
Oskroba DM, Leissing NC, Trissel LA. ()
Hosp Pharm - 1997 - ; 32: 1013-1020.

101

Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions.
Zhang YP, Xu QA, Trissel LA, Gilbert DL, Martinez F. ()
Ann Pharmacotherapy - 1997 - ; 31: 1465-1470.

102

Stability of metoclopramide hydrochloride in plastic syringes.
Zhang Y, Trissel LA, Martinez JF, Gilbert DL. ()
Am J Health-Syst Pharm - 1996 - ; 53: 1300-1302.

103

Concentration-dependent precipitation of sodium bicarbonate with ciprofloxacin lactate.
Trissel LA. ()
Am J Health-Syst Pharm - 1996 - ; 53: 84-85.

104

Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride.
Xu QA, Trissel LA, Martinez JF. ()
Ann Pharmacotherapy - 1996 - ; 30: 756-761.

105

Physical and chemical stability of methotrexate sodium, cytarabine, and hydrocortisone sodium succinate in Elliott’s B solution.
Zhang Y, Xu QA, Trissel LA, Gilbert DL. ()
Hosp Pharm - 1996 - ; 31: 965-970.

106

Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. ()
Am J Health-Syst Pharm - 1996 - ; 53: 1041-1045.

107

Stability of busulfan injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection.
Xu QA, Zhang YP, Trissel LA, Martinez JF. ()
J Oncol Pharm Practice - 1996 - ; 2: 101-105.

108

Screening cladribine for Y-site physical compatibility with selected drugs.
Trissel LA, Martinez JF, Gilbert DL. ()
Hosp Pharm - 1996 - ; 31: 1425-1428.

109

Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility.
Chandler SW, Trissel LA, Weinstein SM ()
J Pain Symptom Manage - 1996 - ; 12, 3: 168-171.

110

Compatibility of amifostine with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. ()
Am J Health-Syst Pharm - 1995 - ; 52: 2208-2212.

111

Compatibility of granisetron hydrochloride with selected alkaline drugs.
Trissel LA, Martinez JF. ()
Am J Health-Syst Pharm - 1995 - ; 52: 208.

112

Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1086-1090.

113

Amphotericin B does not mix with fat emulsion.
Trissel LA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1463-1464.

114

Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration.
Xu QA, Trissel LA, Fox JL. ()
Ann Pharmacotherapy - 1995 - ; 29: 1106-1109.

115

Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium.
Trissel LA, Martinez JF, Xu QA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 710-715.

116

Compatibility and stability of aztreonam and vancomycin hydrochloride.
Trissel LA, Xu QA, Martinez JF. ()
Am J Health-Syst Pharm - 1995 - ; 52: 2560-2564.

117

Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. ()
Am J Hosp Pharm - 1994 - ; 51: 1792-1799.

118

Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets.
Trissel LA, Xu QA, Kwan J, Martinez JF. ()
Am J Hosp Pharm - 1994 - ; 51: 2804-2810.

119

Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. ()
Am J Hosp Pharm - 1994 - ; 51: 1907-1913.

120

Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22 and 32°C.
Trissel LA, Xu QA, Martinez JF, Fox JL. ()
Am J Hosp Pharm - 1994 - ; 51: 2138-2142.

121

Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF. ()
Am J Hosp Pharm - 1994 - ; 51: 672-678.

122

Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Trissel LA, Martinez JF. ()
Am J Hosp Pharm - 1994 - ; 51: 495-499.

123

Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32°C.
Xu QA, Trissel LA, Martinez JF. ()
Am J Hosp Pharm - 1994 - ; 51: 3058-3060.

124

Storage of lorazepam in three injectable solutions in polyvinyl chloride and polyolefin bags.
Trissel LA, Pearson SD. ()
Am J Hosp Pharm - 1994 - ; 51: 368-372.

125

Screening teniposide for Y-site physical incompatibilities.
Trissel LA, Martinez JF. ()
Hosp Pharm - 1994 - ; 29: 1010-1017.

126

Stability and compatibility of minocycline hydrochloride and rifampicin in intravenous solutions at various temperatures.
Pearson SD, Trissel LA. ()
Am J Hosp Pharm - 1993 - ; 50: 698-702.

127

Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components.
Pearson SD, Trissel LA. ()
Am J Hosp Pharm - 1993 - ; 50: 1405-1409.

128

Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Trissel LA, Martinez JF. ()
Am J Hosp Pharm - 1993 - ; 50: 2359-2363.

129

Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
Trissel LA, Martinez JF. ()
Am J Hosp Pharm - 1993 - ; 50: 300-304.

130

Ondansetron compatible with sodium acetate.
Hauser AR, Trissel LA, Martinez JF. ()
J Clin Oncol - 1993 - ; 11: 197.

131

Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection.
Trissel LA, Bready BB. ()
Am J Hosp Pharm - 1992 - ; 49: 1716-1719.

132

Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Trissel LA, Bready BB, Kwan JW, Santiago NM. ()
Am J Hosp Pharm - 1992 - ; 49: 402-406.

133

Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Trissel LA, Tramonte SM, Grilley BJ. ()
Am J Hosp Pharm - 1991 - ; 48: 988-992.

134

Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers.
Waugh WN, Trissel LA, Stella VJ. ()
Am J Hosp Pharm - 1991 - ; 48: 1520-1524.

135

Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Trissel LA, Parks NPT, Santiago NM. ()
Am J Hosp Pharm - 1991 - ; 48: 2186-2189.

136

Aztreonam-vancomycin incompatibility.
Chandler SW, Folstad J, Trissel LA. ()
Am J Hosp Pharm - 1990 - ; 47: 1970.

137

Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
Trissel LA, Chandler SW, Folstad JT. ()
Am J Hosp Pharm - 1990 - ; 47: 2525-2528.

138

Stability and compatibility of antitumor agents in glass and plastic containers.
Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL. ()
Am J Hosp Pharm - 1981 - ; 38: 1914-1918.

молекули изследвани

(244)

		3-4-diaminopyridine
		4-aminopyridine
		Aciclovir sodium
		Alfentanil hydrochloride
		Allopurinol sodium
		Alprostadil
		Alteplase
		Amifostine
		Amikacin sulfate
		Aminocaproic acid
		Aminophylline
		Amiodarone hydrochloride
		Amphotericin B
		Amphotericin B cholesteryl sulfate complex
		Amphotericin B lipid complex
		Amphotericin B liposomale
		Ampicillin sodium
		Ampicillin sodium - sulbactam sodium
		Amsacrine
		Anidulafungin
		Antithymocyte globulin (rabbit)
		Ascorbic acid
		Atenolol
		Atracurium besylate
		Atropine sulfate
		Azithromycine
		Aztreonam
		Bivalirudin
		Bleomycin sulfate
		Bretylium tosilate
		Bumetanide
		Bupivacaine hydrochloride
		Buprenorphine hydrochloride
		Busulfan
		Butorphanol tartrate
		Calcium chloride
		Calcium gluconate
		Carboplatin
		Carmustine
		Caspofungin acetate
		Cefazolin sodium
		Cefepime dihydrochloride
		Cefonicid sodium
		Cefoperazone sodium
		Ceforanide
		Cefotaxime sodium
		Cefoxitin sodium
		Ceftaroline fosamil
		Ceftazidime
		Ceftizoxime sodium
		Ceftobiprole medocaril sodium
		Ceftriaxone disodium
		Cefuroxime sodium
		Chlordiazepoxide hydrochloride
		Chlormethine hydrochloride
		Chlormethine hydrochloride
		Chlorpromazine hydrochloride
		Ciclosporin
		Cimetidine hydrochloride
		Ciprofloxacin lactate
		Cisatracurium besylate
		Cisplatin
		Cladribine
		Clindamycin phosphate
		Clonidine hydrochloride
		Co-trimoxazole
		Cyclophosphamide
		Cytarabine
		Dacarbazine
		Dactinomycin
		Daptomycin
		Daunorubicin hydrochloride
		Dexamethasone sodium phosphate
		Dexmedetomidine
		Dexrazoxane hydrochloride
		Diazepam
		Digoxin
		Diltiazem hydrochloride
		Diphenhydramine hydrochloride
		Dobutamine hydrochloride
		Docetaxel
		Dolasetron mesylate
		Dopamine hydrochloride
		Doripenem
		Doxorubicin hydrochloride
		Doxorubicin hydrochloride liposome peg
		Doxycycline hyclate
		Droperidol
		Enalaprilate
		Ephedrine hydrochloride
		Epinephrine hydrochloride
		Epirubicin hydrochloride
		Eptifibatide
		Ertapenem
		Erythromycin lactobionate
		Esmolol hydrochloride
		Esomeprazole sodium
		Etoposide
		Etoposide phosphate
		Famotidine
		Fenoldopam mesylate
		Fentanyl citrate
		Filgrastim
		Floxuridine
		Fluconazole
		Fludarabine phosphate
		Fluorouracil
		Folinate calcium
		Foscarnet sodium
		Fosphenytoin sodium
		Furosemide
		Gallium nitrate
		Ganciclovir sodium
		Gemcitabine hydrochloride
		Gentamicin sulfate
		Glycopyrronium bromide
		Granisetron hydrochloride
		Haloperidol lactate
		Heparin sodium
		Hetastarch
		Human albumin
		Hydrocortisone sodium succinate
		Hydromorphone hydrochloride
		Hydroxyzine dihydrochloride
		Idarubicin hydrochloride
		Ifosfamide
		Imipenem - cilastatin sodium
		Insulin
		Insulin lyspro
		Iodixanol
		Iohexol
		Irinotecan
		Isoprenaline hydrochloride
		Ketamine hydrochloride
		Ketorolac tromethamine
		Labetalol hydrochloride
		Lansoprazole
		Levofloxacine
		Levofolinate calcium
		Lidocaine hydrochloride
		Linezolid
		Lorazepam
		Magnesium sulfate
		Mannitol
		Melphalan
		Melphalan captisol
		Meropenem
		Mesna
		Metaraminol
		Methadone hydrochloride
		Methohexital sodium
		Methotrexate sodium
		Methylprednisolone sodium succinate
		Metoclopramide hydrochloride
		Metoprolol tartrate
		Metronidazole
		Micafungin
		Midazolam hydrochloride
		Milrinone lactate
		Minocycline hydrochloride
		Mitomycin
		Mitoxantrone dihydrochloride
		Mivacurium
		Morphine hydrochloride
		Morphine sulfate
		Moxifloxacin
		Mycophenolate mofetil
		Nafcillin sodium
		Nalbuphine hydrochloride
		Naloxone hydrochloride
		Naratriptan Hydrochloride
		Neostigmine methylsulfate
		Nesiritide
		Netilmicin sulfate
		Nicardipine hydrochloride
		Nitroglycerin
		Nitroprusside sodium
		Norepinephrine bitartrate
		Octreotide acetate
		Ofloxacin
		Ondansetron hydrochloride
		Oxacillin sodium
		Oxaliplatin
		Oxytocin
		Paclitaxel
		Palonosetron hydrochloride
		Pancuronium bromide
		Pantoprazole sodium
		Papaverine hydrochloride
		Pemetrexed disodium
		Pentamidine isetionate
		Pentobarbital sodium
		Pentostatin
		Pethidine hydrochloride
		Phenobarbital sodium
		Phentolamine mesylate
		Phenylephrine hydrochloride
		Phenytoin sodium
		Piperacillin sodium
		Piperacillin sodium / tazobactam
		Potassium chloride
		Potassium phosphate
		Procainamide hydrochloride
		Prochlorperazine edysilate
		Proflavine
		Promethazine hydrochloride
		Propofol
		Propranolol hydrochloride
		Quinupristine/dalfopristine
		Ranitidine hydrochloride
		Remifentanil hydrochloride
		Reteplase
		Rifampicin
		Rocuronium bromide
		Sargramostim
		Scopolamine hydrobromide
		Sodium bicarbonate
		Sodium Phosphate
		Streptokinase
		Streptozocin
		Sufentanil citrate
		Suxamethonium chloride
		Tacrolimus
		Temozolomide
		Teniposide
		Theophylline
		Thiopental sodium
		Thiotepa
		Ticarcillin / clavulanic acid
		Tigecycline
		Tirofiban
		Tobramycin sulfate
		Topotecan
		Treprostinil
		Vancomycin hydrochloride
		Vasopressin
		Vecuronium bromide
		Verapamil hydrochloride
		Vinblastine sulfate
		Vincristine sulfate
		Vinorelbine tartrate
		Voriconazole
		Warfarin sodium
		Zidovudine

Mentions Légales